Baird downgrades Geron to neutral, cites valuation concerns

TD Cowen starts Geron at buy, cites imetelstat market potential

Skechers Reports Upbeat Earnings, Joins Tutor Perini, AppFolio, Newell Brands And Other Big Stocks Moving Higher On Friday

Geron to Announce First Quarter 2024 Financial Results on May 2, 2024

3 Red-Hot Biotech Rockets Blasting Off in 2024

Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Geron Corporation (NASDAQ:GERN) Is Expected To Breakeven In The Near Future

Cramer's Lightning Round: Trade Desk is 'great'

Geron to Participate at Upcoming Investor Conferences in April

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

Biotech Stock Roundup: GERN, CRNX Gain on Updates, BMY's CAR T Cell Therapy News & More

Geron Corporation Announces Pricing of $150 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

Company News for Mar 18, 2024

Geron, Madrigal Pharmaceuticals jump on good news from FDA

Stocks making the biggest moves midday: Adobe, Ulta, Micron Technology, Rivian Automotive and more

Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up

Geron (GERN) Gets ODAC Votes for Blood Disorder Drug, Shares Up

Geron Stock Is Soaring After Hours: What's Going On?

Geron Announces FDA Oncologic Drugs Advisory Committee Votes in Favor of the Clinical Benefit/Risk Profile of Imetelstat for the Treatment of Transfusion-Dependent Anemia in Patients with Lower-Risk MDS

Geron's blood disorder drug gets FDA advisers' backing